FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

KVK Tech Indomethacin Extended-Release Capsules Recall

Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd

KVK Tech, Inc. · Newtown, PA

Risk level
Class II
Reported by FDA
May 28, 2025
Recall ID
D-0445-2025
Check your lot numberHow we source this data

Summary

KVK Tech recalled Indomethacin Extended-Release Capsules starting May 9, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0445-2025 on May 28, 2025. Reason: cGMP deviations. Status: Ongoing.

Why it was recalled

cGMP deviations

Product description

Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01.

Lot numbers, UPCs & expiration codes

Lot#: 18400A, Exp 7/31/2027

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0445-2025
Classification
Class II
Status
Ongoing
Recall initiated
May 9, 2025
FDA report date
May 28, 2025
Quantity
9107 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
KVK Tech, Inc.

Original FDA data

Every field from FDA enforcement report D-0445-2025, exactly as published.

Show all FDA fields
City
Newtown
State
PA
Status
Ongoing
Country
United States
Event ID
96847
Address
110 Terry Dr
Code information
Lot#: 18400A, Exp 7/31/2027
Postal code
18940-3427
Report date
May 28, 2025
Product type
Drugs
Recall number
D-0445-2025
Classification
Class II
Recalling firm
KVK Tech, Inc.
Product quantity
9107 bottles
Reason for recall
cGMP deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01.
Distribution pattern
Nationwide
Recall initiation date
May 9, 2025
Initial firm notification
E-Mail
Center classification date
May 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0445-2025, published May 28, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls